Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMADEO: Telmisartan vs Losartan in Diabetic Nephropathy
NCT00168857Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2003
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 4, randomised, double-blind trial of telmisartan in diabetic nephropathy (DN) and hypertension (HTN) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change in urinary protein to creatinine ratio at 1 year. Started Jul 2003; status: completed.
02
Drugs
telmisartan
03
Conditions
diabetic nephropathy (DN)hypertension (HTN)
Beyond the preview
Go deeper on NCT00168857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168857.